<DOC>
	<DOC>NCT02273960</DOC>
	<brief_summary>The purpose of this study is to assess the safety and tolerability of BMS-986004 when administered in subjects with ITP.</brief_summary>
	<brief_title>Study to Evaluate Safety and Efficacy in Adult Subjects With ITP</brief_title>
	<detailed_description />
	<mesh_term>Purpura, Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura, Thrombocytopenic, Idiopathic</mesh_term>
	<criteria>For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com â‰¥18 years old, diagnosed with persistent or chronic ITP Secondary immune thrombocytopenia Drug induced thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>